title: Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
authors.affiliation: Department of Haematology/Oncology, Prince of Wales Children's Hospital, Randwick, New South Wales, Australia.
authors.forename: P R
authors.initials: PR
authors.lastname: Lam-Po-Tang
authors.forename: G B
authors.initials: GB
authors.lastname: McCowage
authors.forename: M R
authors.initials: MR
authors.lastname: Vowels
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D009447:Neuroblastoma / Q000628:therapy*; D011379:Prognosis; D013713:Teniposide / Q000008:administration & dosage; D014182:Transplantation, Autologous; D014916:Whole-Body Irradiation
chemical_list: D004317:Doxorubicin; D013713:Teniposide; D002945:Cisplatin; D008558:Melphalan